[Meta] the Zepbound rule is doing its job and people should stop complaining
the Zepbound rule is doing its job and people should stop complaining — with the counter-argument included, because I find it fairly persuasive.
Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
I will update this if the picture changes rather than quietly leaving it up.
best — the order this archive was captured in
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.
This matches mine. Milder nausea than I expected, and what there was settled inside a fortnight of each step.
SURMOUNT-1 landed around 21% at 72 weeks on the top arm
if 7.5 is working, 10 is not automatically better
the trials titrated on a calendar, real people titrate on symptoms
Same experience with the appetite effect being flatter across the week rather than front-loaded.
Sulphur burps for the first eight days after each step, then nothing. Predictable enough that I planned my week around it.
I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your constipation pattern is a guess.
the nausea profile is genuinely gentler than people expect coming from sema
Yes — 10mg being a genuine landing place for a lot of people is underrated. There is no medal for 15.
hold the dose that works, the ladder is not a leaderboard
the four-week step schedule is the label, not folklore
stepping every four weeks is a ceiling on speed, not a schedule you must hit
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
Removed the conversion table. There is no published equivalence between the two molecules and posting one as fact is exactly the kind of thing that gets copied for years.
the appetite effect is blunter than sema, in a good way, most weeks
- 1SURMOUNT-1 landed around 21% at 72 weeks on the top arm12 comments in this branch · started by u/bastian_eriksen